Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 11, 2023 16:16 ET | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Fate Therapeutics (FATE) Investors with $100K+ Losses to Contact Firm’s Attorneys Before Mar. 22nd Deadline in Securities Class Action

SAN FRANCISCO, March 11, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Fate Therapeutics, Inc. (NASDAQ: FATE) investors who suffered significant losses to submit your losses now. Class Period: Apr....
January 30, 2023 15:43 ET | Source: Hagens Berman Sobol Shapiro LLP

FATE CLASS ACTION: Hagens Berman, National Trial Attorneys, Encourages Fate Therapeutics, Inc. (FATE) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed

SAN FRANCISCO, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Fate Therapeutics, Inc. (NASDAQ: FATE) investors who suffered significant losses to submit your losses now. Class Period: Apr....
January 24, 2023 14:38 ET | Source: Hagens Berman Sobol Shapiro LLP

YMAB DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Y-mAbs Therapeutics (YMAB) Investors with Significant Losses to Contact the Firm’s Attorneys Before Application Deadline in Securities Fraud Class Action

SAN FRANCISCO, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) investors who suffered significant losses to submit your losses now. Class Period: Oct....
January 18, 2023 17:25 ET | Source: Hagens Berman Sobol Shapiro LLP

FATE INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Fate Therapeutics, Inc. (FATE) Investors with Significant Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

SAN FRANCISCO, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Fate Therapeutics, Inc. (NASDAQ: FATE) investors who suffered significant losses to submit your losses now. Visit:...
January 10, 2023 18:01 ET | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, National Trial Attorneys, Encourages Fate Therapeutics, Inc. (FATE) Investors with Significant Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

SAN FRANCISCO, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Fate Therapeutics, Inc. (NASDAQ: FATE) investors who suffered significant losses to submit your losses now. Visit:...